Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 290.00
Bid: 294.00
Ask: 295.50
Change: 0.50 (0.17%)
Spread: 1.50 (0.51%)
Open: 298.00
High: 298.00
Low: 284.50
Prev. Close: 289.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

28 Oct 2014 07:00

RNS Number : 4095V
Synthomer PLC
28 October 2014
 



28th October 2014

 

Synthomer plc

 

Interim Management Statement

 

Synthomer plc ("Synthomer" or "the Group") today issues its Interim Management Statement for the period 1 July to 28 October 2014.

 

Trading

 

At our interim results on August 11th 2014, we reported firmer demand in our European and North America (ENA) segment, particularly in construction. Unfortunately this improved demand trend has not persisted through the third quarter and volumes, excluding business that we deliberately exited in compounds as reported in half one, were down 3% in ENA. Despite this, unit cash margins continued to firm as a result of our active margin management strategy, and year-to-date average margins in ENA are now ahead of the 2013 average. However, on a local currency basis, as at the end of the third quarter, year-to-date operating profit was slightly down on the prior year.

 

In our Asia and Rest of the World (ARW) segment, volumes increased by 1.3% in the quarter. Volumes have been impacted somewhat by our market activities to improve unit cash margins in the nitrile business, where we have made good progress. We remain positive about continuing demand growth in the nitrile latex market.

 

Financial Position

 

The balance sheet remains in a strong position with the net debt / EBITDA ratio at approximately 1x.

 

We completed the purchase of the other 50% of our EKA Synthomer JV in Finland in October from Akzo Nobel for €5 million. The entity has some €6 million of debt at the transaction date which will be consolidated at the year end, meaning year end net debt for the Group will be slightly higher than previous expectations, and is likely to be similar to the mid-year position.

 

Consistent with our capital management policy articulated at the interim results, if excess capital has not been deployed for either bolt-on acquisitions or capital expenditure, at the year end the Board will consider a one-off capital return to shareholders to maintain an efficient balance sheet.

 

Outlook

At current run rates and given the current demand environment in Europe, the Board now expects full year profit-before-tax to be slightly below current consensus1. We are cautious about performance in Europe given recent economic developments, and should this impact demand further than currently anticipated in the fourth quarter, then profit-before-tax is likely to be around the lower end of the current consensus range2.

 

1. Company compiled 2014 consensus PBT: £87.8 million

2. Company compiled 2014 consensus PBT range: £81.3million - £90.3 million

 

  

Enquiries:

 

Adrian Whitfield, Chief Executive Officer

Charles Armitstead / Rebecca Hall

David Blackwood, Chief Financial Officer

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

 

 

The company will host a conference call for analysts at 8.30am today. Please contact Pendomer Communications on 020 3603 5220 for dial in details.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUBVNRSRARUAA
Date   Source Headline
4th Feb 201011:38 amRNSHolding(s) in Company
12th Jan 20107:00 amRNSTrading Update
25th Nov 200910:02 amRNSHolding(s) in Company
18th Nov 20099:28 amRNSHolding(s) in Company
19th Oct 20097:00 amRNSInterim Management Statement
2nd Sep 200910:14 amRNSHolding(s) in Company
24th Aug 20097:00 amRNSHalf Yearly Report
23rd Jun 20097:00 amRNSPre-close Trading Update
18th May 20099:16 amRNSDirector/PDMR Shareholding
14th May 200912:40 pmRNSResult of AGM
14th May 20097:00 amRNSAGM & Interim Management Statement
1st May 20097:00 amRNSAppointment of new joint brokers
21st Apr 20094:20 pmRNSAnnual Information Update
15th Apr 20099:24 amRNSAnnual Financial Report
23rd Mar 20094:03 pmRNSHolding(s) in Company
23rd Mar 20094:01 pmRNSHolding(s) in Company
20th Mar 200910:31 amRNSDirector/PDMR Shareholding
19th Mar 20097:00 amRNSAppointment of Senior Independent Director
16th Mar 20094:54 pmRNSDirector/PDMR Shareholding
12th Mar 20092:35 pmRNSDirector/PDMR Shareholding
12th Mar 20092:31 pmRNSDirector/PDMR Shareholding
11th Mar 20094:18 pmRNSDirector/PDMR Shareholding
11th Mar 20097:00 amRNSFinal Results
4th Mar 20094:35 pmRNSPrice Monitoring Extension
4th Mar 20091:57 pmRNSAppointment of non-executive director
13th Feb 20094:40 pmRNSSecond Price Monitoring Extn
13th Feb 20094:35 pmRNSPrice Monitoring Extension
30th Jan 20093:54 pmRNSNew Loan Facility / Completion of Disposal
21st Jan 20097:00 amRNSAppointment of new Chairman
19th Jan 20094:29 pmRNSDirector/PDMR Shareholding
15th Jan 20091:59 pmRNSDirector/PDMR Shareholding
13th Jan 200912:33 pmRNSHolding(s) in Company
7th Jan 20095:29 pmRNSDirector/PDMR Shareholding
5th Jan 200911:17 amRNSDisposal
29th Dec 20087:00 amRNSUpdate
12th Dec 200810:08 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSSale of PFW Aroma Chemicals BV
3rd Dec 200810:57 amRNSBlocklisting Interim Review
20th Nov 20084:47 pmRNSSecond Price Monitoring Extn
20th Nov 20084:39 pmRNSPrice Monitoring Extension
14th Nov 20087:00 amRNSInterim Management Statement
10th Nov 20083:04 pmRNSHolding(s) in Company
6th Nov 20084:37 pmRNSPrice Monitoring Extension
21st Oct 20086:24 pmRNSHolding(s) in Company
21st Oct 20086:24 pmRNSHolding(s) in Company
8th Sep 20084:41 pmRNSSecond Price Monitoring Extn
8th Sep 20084:36 pmRNSPrice Monitoring Extension
2nd Sep 200812:26 pmRNSHolding(s) in Company
27th Aug 20087:00 amRNSInterim Results
14th Aug 20088:59 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.